CTSOVSDCOY• 12 Months (Normalized)
CTSO vs DCOY (Cytosorbents Corporation vs Decoy Therapeutics Inc.)
Showing Closing Date Range from Oct 1, 2025 to Oct 1, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $3.9
+318.01%
Cytosorbents Corporation
Normalized Baseline0.00%
DCOY Performance $1.97
-95.68%
Decoy Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+413.69 pts
CTSO outperforming by 413.69 percentage points
CTSODCOY
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO DCOY
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | CTSO Price | CTSO Gain (%) | DCOY Price | DCOY Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 30, 2026 | $3.90 | +318.01% | $1.97 | -95.68% | +413.69% |
| Sep 29, 2026 | $4.00 | +328.72% | $2.13 | -95.33% | +424.05% |
| Sep 28, 2026 | $4.02 | +330.87% | $2.31 | -94.93% | +425.80% |
| Sep 25, 2026 | $4.38 | +369.45% | $3.09 | -93.22% | +462.67% |
| Sep 24, 2026 | $4.30 | +360.88% | $3.11 | -93.18% | +454.06% |
| Sep 23, 2026 | $4.91 | +426.26% | $3.85 | -91.56% | +517.82% |
| Sep 22, 2026 | $- | $3.10 | -93.20% | - | |
| Sep 21, 2026 | $5.51 | +490.57% | $2.56 | -94.39% | +584.96% |
| Sep 18, 2026 | $5.75 | +516.29% | $2.78 | -93.90% | +610.19% |
| Sep 17, 2026 | $5.76 | +517.36% | $2.83 | -93.79% | +611.15% |
| Sep 16, 2026 | $5.73 | +514.15% | $2.89 | -93.66% | +607.81% |
| Sep 15, 2026 | $6.06 | +549.52% | $2.71 | -94.06% | +643.58% |
| Sep 14, 2026 | $6.07 | +550.59% | $2.71 | -94.06% | +644.65% |
| Sep 11, 2026 | $6.41 | +587.03% | $2.67 | -94.14% | +681.17% |
| Sep 10, 2026 | $6.37 | +582.74% | $2.73 | -94.01% | +676.75% |
Page 1 of 17